The Oakmark Funds are advised by Harris Associates L.P. an autonomous subsidiary of Natixis Investment Managers, L.P.
Learn more about the principles and philosophy behind our funds at HarrisAssoc.com.
Partner and Portfolio Manager
Eric Liu has been a manager of the Oakmark Global Select Fund since 2016, the Oakmark International Fund since 2023 and the Oakmark Global Fund since 2024. He is also an investment analyst on the international research team and a vice president of the Oakmark Funds.
He joined Harris Associates in 2009 after serving as a research associate at Dodge & Cox and an investment banking analyst at Jefferies & Company.
Mr. Liu earned a B.A. degree in economics and philosophy from the University of California Los Angeles (2001) and an M.B.A. from the University of Chicago (2009).
Insights
October 14, 2024
Portfolio Manager Eric Liu discusses Harris | Oakmark’s long-term outlook and how it’s used to identify opportunities in international equities.
News
July 1, 2024
Eric Liu, co-portfolio manager of the Oakmark International and Oakmark Global Select Funds and a senior investment analyst at Harris Associates L.P., adviser to...
Insights
November 1, 2021
Portfolio Manager Eric Liu discusses how Oakmark measures risk in Chinese equity markets.
At Oakmark, we don’t have an opinion about how equities will perform this year, if a recession will start or if the political parties will produce pro-growth candidates during the next election cycle. As long-term investors, we don’t think it matters.
Commentary
Oakmark Global Select Fund: First Calendar Quarter 2025
March 31, 2025
The Fund had a strong quarter; a financial holding was a top contributor, while a technology company was a top detractor.
Oakmark International Fund: First Calendar Quarter 2025
March 31, 2025
The Fund outpaced its benchmark this quarter; a financial holding was a top contributor while a communications company was a top detractor.
Oakmark Global Select Fund: Fourth Calendar Quarter 2024
December 31, 2024
A top contributor to the Fund’s performance was a U.S.-headquartered consumer finance company, while a top detractor was a Germany-headquartered agriculture and pharma company.